메뉴 건너뛰기
Drug Discovery Today
Volumn 9, Issue 21, 2004, Pages 906-907
Zebularine: A candidate for epigenetic cancer therapy

(1)  Bradbury, Jane a  

a NONE
Author keywords

Biochemistry; Cancer biology; DNA methylation; Drug Discovery; Genetic imprinting; Histone deacetylase; Myelodysplastic syndrome; Nucleoside analogues; Pharmaceutical Science
Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CYTIDINE DERIVATIVE; PROCAINAMIDE; VORINOSTAT; ZEBULARINE;
EID: 6344261800     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03266-0     Document Type: Short Survey
Times cited : (8)
References (4)
  • 1
    • 5144228492 scopus 로고    scopus 로고
    • Preferential response of cancer cells to zebularine
    • Cheng J.C., et al. Preferential response of cancer cells to zebularine. Cance Cell. 6:2004;151-158
    • (2004) Cance Cell , vol.6 , pp. 151-158
    • Cheng, J.C.1
  • 2
    • 2642531973 scopus 로고    scopus 로고
    • Epigenetics in human disease and prospects for epigenetic therapy
    • Egger G., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 429:2004;457-463
    • (2004) Nature , vol.429 , pp. 457-463
    • Egger, G.1
  • 3
    • 4444325603 scopus 로고    scopus 로고
    • Demethylation of DNA by decitabine in cancer chemotherapy
    • Brown R., Plumb J.A. Demethylation of DNA by decitabine in cancer chemotherapy. Anticancer Ther. 4:2004;501-510
    • (2004) Anticancer Ther. , vol.4 , pp. 501-510
    • Brown, R.1    Plumb, J.A.2
  • 4
    • 0035997960 scopus 로고    scopus 로고
    • Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment
    • Reid G.K., et al. Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment. Drug Discov. 4:2002;130-137
    • (2002) Drug Discov , vol.4 , pp. 130-137
    • Reid, G.K.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.